Your account is not claimed yet. You can sign up with ORCID to claim your account.

Tuomas Mirtti (T Mirtti)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 26

Top Venues

International journal of cancer

Cancers

Scientific reports

Cancer research communications

University of Helsinki (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Helsinki Sep 1o 2008

Finland

PHD :: Department of Pathology

Publications

Moon Hee Lee, Jason Theodoropoulos, Jani Huuhtanen, Dipabarna Bhattacharya, Petrus Järvinen, Sara Tornberg, Harry Nísen, Tuomas Mirtti, Ilona Uski, Anita Kumari, Karita Peltonen, Arianna Draghi, Marco Donia, Anna Kreutzman, Mohamed El Missiry
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma. Cancer research communications 3 (7) (2023)
Hannu Koistinen, Ruusu-Maaria Kovanen, Morley D Hollenberg, Antoine Dufour, Evette S Radisky, Ulf-Håkan Stenman, Jyotsna Batra, Judith A Clements, John D Hooper, Eleftherios P Diamandis, Oliver Schilling, Antti S Rannikko, Tuomas Mirtti
The roles of proteases in prostate cancer. IUBMB life (2023)
Hannu Koistinen, Ruusu-Maaria Kovanen, Morley D Hollenberg, Antoine Dufour, Evette S Radisky, Ulf-Håkan Stenman, Jyotsna Batra, Judith A Clements, John D Hooper, Eleftherios P Diamandis, Oliver Schilling, Antti S Rannikko, Tuomas Mirtti
The roles of proteases in prostate cancer. IUBMB life (2023)
Timo-Pekka K Lehto, Juho Pylväläinen, Kevin Sandeman, Anu Kenttämies, Stig Nordling, Ian G Mills, Jing Tang, Tuomas Mirtti, Antti S Rannikko
Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosis. International journal of cancer (2023)
Tolou Shadbahr, Michael Roberts, Jan Stanczuk, Julian Gilbey, Philip Teare, Sören Dittmer, Matthew Thorpe, Ramon Viñas Torné, Evis Sala, Pietro Lió, Mishal Patel, Jacobus Preller, null null, James H F Rudd, Tuomas Mirtti, Antti Sakari Rannikko, John A D Aston, Jing Tang, Carola-Bibiane Schönlieb
The impact of imputation quality on machine learning classifiers for datasets with missing values. Communications medicine 3 (1) (2023)
Rim Bouslama, Vincent Dumont, Sonja Lindfors, Lassi Paavolainen, Jukka Tienari, Harry Nisen, Tuomas Mirtti, Moin A Saleem, Daniel Gordin, Per-Henrik Groop, Shiro Suetsugu, Sanna H Lehtonen
Phosphorylation of PACSIN2 at S313 Regulates Podocyte Architecture in Coordination with N-WASP. Cells 12 (11) (2023)
Timo-Pekka K Lehto, Ruusu-Maaria Kovanen, Susanna Lintula, Adrian Malén, Carolin Stürenberg, Andrew M Erickson, Olli-Pekka Pulkka, Ulf-Håkan Stenman, Eleftherios P Diamandis, Antti S Rannikko, Tuomas Mirtti, Hannu Koistinen
Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancer. International journal of cancer (2023)
Timo-Pekka K Lehto, Ruusu-Maaria Kovanen, Susanna Lintula, Adrian Malén, Carolin Stürenberg, Andrew M Erickson, Olli-Pekka Pulkka, Ulf-Håkan Stenman, Eleftherios P Diamandis, Antti S Rannikko, Tuomas Mirtti, Hannu Koistinen
Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancer. International journal of cancer (2023)
Veronique Ouellet, Andrew Erickson, null null, Kathy Wiley, Colm Morrissey, Viktor Berge, Carlos S Moreno, Kristin Austlid Tasken, Dominique Trudel, Lawrence D True, Michael S Lewis, Aud Svindland, Onur Ertunc, Igor Damasceno Vidal, Adeboye O Osunkoya, Tracy Jones, G Steven Bova, Tarja Lamminen, Ariel H Achtman, Mark Buzza, Michelle M Kouspou, Steven A Bigler, Xinchun Zhou, Stephen J Freedland, Anne-Marie Mes-Masson, Isla P Garraway, Bruce J Trock, Pekka Taimen, Fred Saad, Tuomas Mirtti, Beatrice S Knudsen, Angelo M DeMarzo
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (4) (2022)
Lan Yu, Mervi Toriseva, Syeda Afshan, Mario Cangiano, Vidal Fey, Andrew Erickson, Heikki A Seikkula, Kalle Alanen, Pekka Taimen, Otto Ettala, Martti Nurmi, Peter J Boström, Markku Kallajoki, Johanna Tuomela, Tuomas Mirtti, Inès J Beumer, Matthias Nees, Pirkko Härkönen
Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression. Cancers 14 (2) (2022)
Moon Hee Lee, Petrus Järvinen, Harry Nísen, Oscar Brück, Mette Ilander, Ilona Uski, Jason Theodoropoulos, Matti Kankainen, Tuomas Mirtti, Mohamed El Missiry, Anna Kreutzman
T and NK cell abundance defines two distinct subgroups of renal cell carcinoma. Oncoimmunology 11 (1) (2022)
Antti S Rannikko, Mare Leht, Tuomas Mirtti, Anu Kenttämies, Teemu Tolonen, Irina Rinta-Kiikka, Tuomas P Kilpeläinen, Kari Natunen, Hans G Lilja, Terho Lehtimäki, Jani Raitanen, Paula Kujala, Johanna Ronkainen, Mika Matikainen, Anssi Petas, Kimmo Taari, Teuvo L J Tammela, Anssi Auvinen
Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study. BJU international 130 (2) (2022)
Kevin Sandeman, Sami Blom, Ville Koponen, Anniina Manninen, Juuso Juhila, Antti Rannikko, Tuomas Ropponen, Tuomas Mirtti
AI Model for Prostate Biopsies Predicts Cancer Survival. Diagnostics (Basel, Switzerland) 12 (5) (2022)
Teijo Pellinen, Kevin Sandeman, Sami Blom, Riku Turkki, Annabrita Hemmes, Katja Välimäki, Juho Eineluoto, Anu Kenttämies, Stig Nordling, Olli Kallioniemi, Antti S Rannikko, Tuomas Mirtti
Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer. Cancer research communications 2 (3) (2022)
Teijo Pellinen, Kevin Sandeman, Sami Blom, Riku Turkki, Annabrita Hemmes, Katja Välimäki, Juho Eineluoto, Anu Kenttämies, Stig Nordling, Olli Kallioniemi, Antti S Rannikko, Tuomas Mirtti
Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer. Cancer research communications 2 (3) (2022)
Maija Puhka, Lisse Thierens, Daniel Nicorici, Tarja Forsman, Tuomas Mirtti, Taija Af Hällström, Elina Serkkola, Antti Rannikko
Exploration of Extracellular Vesicle miRNAs, Targeted mRNAs and Pathways in Prostate Cancer: Relation to Disease Status and Progression. Cancers 14 (3) (2022)
Lassi Luomala, Juhana Rautiola, Petrus Järvinen, Tuomas Mirtti, Harry Nísen
Active surveillance versus initial surgery in the long-term management of Bosniak IIF-IV cystic renal masses. Scientific reports 12 (1) (2022)
Sonja Lindfors, Zydrune Polianskyte-Prause, Rim Bouslama, Eero Lehtonen, Miia Mannerla, Harry Nísen, Jukka Tienari, Hanne Salmenkari, Richard A Forsgård, Tuomas Mirtti, Markku Lehto, Per-Henrik Groop, Sanna H Lehtonen
Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo. Diabetologia 64 (8) (2021)
Timo-Pekka K Lehto, Carolin Stürenberg, Adrian Malén, Andrew M Erickson, Hannu Koistinen, Ian G Mills, Antti S Rannikko, Tuomas Mirtti
Transcript analysis of commercial prostate cancer risk stratification panels in hard-to-predict grade group 2-4 prostate cancers. The Prostate 81 (7) (2021)
Eduard Chelebian, Christophe Avenel, Kimmo Kartasalo, Maja Marklund, Anna Tanoglidi, Tuomas Mirtti, Richard Colling, Andrew M Erickson, Alastair D Lamb, Joakim Lundeberg, Carolina Wählby
Morphological Features Extracted by AI Associated with Spatial Transcriptomics in Prostate Cancer. Cancers 13 (19) (2021)
I Koskinen, P J Boström, P Taimen, A Salminen, M Tervahartiala, J Sairanen, A Erickson, Tuomas Mirtti
Prediction of neo-adjuvant chemotherapy response in bladder cancer: the impact of clinical parameters and routine biomarkers. Scandinavian journal of urology 55 (6) (2021)
Andrew M Erickson, Utku Lokman, Kanerva Lahdensuo, Sara Tornberg, Harri Visapaa, Robin Bergroth, Henrikki Santti, Anssi Petas, Antti S Rannikko, Tuomas Mirtti
PTEN and ERG expression in MRI-ultrasound guided fusion biopsy correlated with radical prostatectomy findings in men with prostate cancer. The Prostate 80 (13) (2020)
Victor Cervera-Carrascon, Dafne C A Quixabeira, Joao Manuel Santos, Riikka Havunen, Sadia Zafar, Otto Hemminki, Camilla Heiniö, Eleonora Munaro, Mikko Siurala, Suvi Sorsa, Tuomas Mirtti, Petrus Järvinen, Markus Mildh, Harry Nisen, Antti S Rannikko, Marjukka Anttila, Anna Kanerva, Akseli Hemminki
Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition. Oncoimmunology 9 (1) (2020)
Teijo Pellinen, Sami Blom, Sara Sánchez, Katja Välimäki, John-Patrick Mpindi, Hind Azegrouz, Raffaele Strippoli, Raquel Nieto, Mariano Vitón, Irene Palacios, Riku Turkki, Yinhai Wang, Miguel Sánchez-Alvarez, Stig Nordling, Anna Bützow, Tuomas Mirtti, Antti Rannikko, María C Montoya, Olli Kallioniemi, Miguel A Del Pozo
ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer. Scientific reports 8 (1) (2018)
Johan Stranne, Martin Andreas Røder, B Brennhovd, E Johansson, Fredrik Jäderling, M Kouri, Wolfgang A Lilleby, P Meidahl Petersen, Tuomas Mirtti, A Pettersson, Antti S Rannikko, Camilla Thellenberg Karlsson, Olof Akre
SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer. Scandinavian journal of urology 52 (5-6) (2018)
Minna Tervahartiala, Pekka Taimen, Tuomas Mirtti, Ilmari Koskinen, Thorsten Ecke, Sirpa Jalkanen, Peter J Boström
Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer. Scientific reports 7 (1) (2017)

Tuomas Mirtti.css-eqlu8i{font-size:small;padding-left:4px;} (T Mirtti)

Publication Activity (10 Years)

Top Topics

Top Venues

Tuomas Mirtti (T Mirtti)